Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AmberHealth vs Breeze Meds

AmberHealth
Graded #31

Higher grade

vs+10.5
Breeze Meds
Graded #56

Lower grade

The verdict

AmberHealth takes it — 82.9/100 to 72.4/100.

AmberHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmberHealth +18
90
72
Dose & formulationAmberHealth +14
80
66
Clinical oversightAmberHealth +3
79
76
Labs & monitoringAmberHealth +18
78
60
FulfillmentAmberHealth +2
86
84
Contract termsBreeze Meds +4
82
86
AmberHealth · left barBreeze Meds · right bar

The numbers

MetricAmberHealthBreeze Meds
WeighScore82.9/10072.4/100
GradeB−C
Scorecard rank#31#56
Semaglutide$100/moFrom $199/mo
Tirzepatide$175/moFrom $299/mo first month, $399/mo thereafter
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AmberHealth

Graded #31 · B−

Strengths

  • $100 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Tirzepatide $175
  • Monitoring detail sparse
Breeze Meds

Graded #56 · C

Strengths

  • Nothing charged until a provider approves you, and the consult is free if you go ahead
  • One inclusive price covering consult, medication, supplies, shipping and support
  • LegitScript certified, all 50 states, cancel or change plan at any time
  • NAD+ injections offered alongside the GLP-1 line

Where it loses points

  • The public site names no molecule behind its "from $199" — tirzepatide pricing appears only inside the intake
  • Every quoted figure is for the LOWEST dose; the funnel says higher doses may cost more
  • An $80 consultation fee applies if you are approved and then decline
  • Injection only, compounded only, with no published lab programme

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard